Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Nuclear receptor ROR-gamma | ||
Ligand | BDBM362923 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | Binding Assay | ||
Ki | <100±n/a nM | ||
Citation | Claremon, DA; Dillard, LW; Dong, C; Fan, Y; Jia, L; Lotesta, SD; Marcus, A; Singh, SB; Tice, CM; Yuan, J; Zhao, W; Zheng, Y; Zhuang, L Isoindoline inhibitors of ROR-gamma US Patent US9845308 Publication Date 12/19/2017 | ||
More Info.: | Get all data from this article, Assay Method | ||
Nuclear receptor ROR-gamma | |||
Name: | Nuclear receptor ROR-gamma | ||
Synonyms: | NR1F3 | Nuclear receptor ROR-gamma | Nuclear receptor ROR-gamma (RORC) | Nuclear receptor subfamily 1 group F member 3 | RAR-related orphan receptor C (RORc) | RORC | RORG | RORG_HUMAN | RZRG | Retinoid-related orphan receptor-gamma | Retinoid-related orphan receptor-gamma (RORc) | ||
Type: | Enzyme Catalytic Domain | ||
Mol. Mass.: | 58218.40 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P51449 | ||
Residue: | 518 | ||
Sequence: |
| ||
BDBM362923 | |||
n/a | |||
Name | BDBM362923 | ||
Synonyms: | (S)-N-((5-(ethylsulfonyl)pyridin-2-yl)methyl)-1-isopropyl-2-((2-(trifluoromethyl)-1,3-dioxan-5-yl)methyl)isoindoline-5-carboxamide (32a and 32b) | US9845308, Example 32a | US9845308, Example 32b | ||
Type | Small organic molecule | ||
Emp. Form. | C26H32F3N3O5S | ||
Mol. Mass. | 555.61 | ||
SMILES | CCS(=O)(=O)c1ccc(CNC(=O)c2ccc3[C@H](C(C)C)N(C[C@H]4CO[C@H](OC4)C(F)(F)F)Cc3c2)nc1 |r,wU:23.22,26.29,wD:17.17,(10.83,-9.4,;9.5,-8.63,;8.16,-9.4,;7.39,-10.73,;8.93,-10.73,;6.83,-8.63,;6.83,-7.09,;5.5,-6.32,;4.16,-7.09,;2.83,-6.32,;1.49,-7.09,;.16,-6.32,;.16,-4.78,;-1.17,-7.09,;-1.17,-8.63,;-2.51,-9.4,;-3.84,-8.63,;-5.3,-9.1,;-5.7,-10.59,;-7.19,-10.99,;-4.61,-11.68,;-6.21,-7.86,;-7.75,-7.86,;-8.52,-6.52,;-10.06,-6.52,;-10.83,-5.19,;-10.06,-3.85,;-8.52,-3.85,;-7.75,-5.19,;-10.83,-2.52,;-10.06,-1.19,;-12.37,-2.52,;-11.6,-1.19,;-5.3,-6.61,;-3.84,-7.09,;-2.51,-6.32,;4.16,-8.63,;5.5,-9.4,)| | ||
Structure |